Updates

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Oct 16, 2025

Big Pharma Company Beats Wall Street Expectations Following Price Hikes on… Read More

CSRxP: PERA WOULD FURTHER ENABLE BIG PHARMA’S PATENT ABUSE THAT KEEPS PRESCRIPTION DRUG PRICES HIGH

Oct 7, 2025

Senate Judiciary Lawmakers Should Reject Big Pharma-Backed Proposal and… Read More

SECOND OPINION: BIG PHARMA’S RHETORIC OF DEFLECTION DOESN’T ADDRESS CAUSE OF HIGH PRESCRIPTION DRUG PRICES

Oct 6, 2025

PhRMA Continues to Dodge Responsibility for Egregious Pricing Practices and… Read More

DOSE OF REALITY: BIG PHARMA’S QUICK DELISTING OF MORE THAN 40 SHAM PATENTS HIGHLIGHTS SCALE OF PATENT THICKETS ON TOP MONEY-MAKERS

Sep 18, 2025

Analysis Finds Brand Name Drug Companies Declined to Even Attempt a Defense of… Read More

U.S. HOUSE COMMITTEE SHOULD ADVANCE Q1/Q2 REFORMS TO PROMOTE GREATER COMPETITION AND HELP LOWER PRESCRIPTION DRUG PRICES

Sep 17, 2025

Lawmakers Should Advance Bipartisan, Market-Based Solution to Crack Down on… Read More

DOSE OF REALITY: STUDY FINDS BIG PHARMA’S PATENT THICKETS ON JUST FOUR BRAND NAME DRUGS COST MORE THAN $3.5 BILLION IN TWO YEARS

Sep 3, 2025

Patent Abuse Blocked Competition From More Affordable Alternatives For Periods… Read More